Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Clinical trial NCT06164743 · COMPLETED
Trial details
- NCT number
- NCT06164743
- Sponsor
- VivaVision Biotech, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-11
- Primary completion
- 2024-05-15
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.